GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 0.684 | 25411331
|
ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | FACs followed by RT-PCR | NA | 0.52 | 0.684 | 27694834
|
ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.684 | 34059086
|
ALDH1A1 | 402 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.684 | 31100681
|
PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting and IF staining | NA | 0.52 | 0.7582 | 25411331
|
PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | Cisplatin | Western Blotting followed by FACs | NA | 0.52 | 0.7582 | 30754694
|
PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | FACs followed by RT-PCR | NA | 0.52 | 0.7582 | 27694834
|
PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.7582 | 34059086
|
PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.7582 | 34059086
|
PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting | NA | 0.52 | 0.7582 | 31100681
|
PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting and SP assay | NA | 0.52 | 0.7582 | 26911281
|
PROM1 | 9454 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | RT-PCR | NA | 0.52 | 0.7582 | 32090054
|
CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | Western Blotting followed by FACs | NA | 0.4 | 1 | 30754694
|
CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | FACs followed by RT-PCR | NA | 0.4 | 1 | 27694834
|
CD44 | 1681 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting | NA | 0.4 | 1 | 34059086
|
CD24 | 1645 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | FACs followed by RT-PCR | NA | 0.32 | 0.456 | 27694834
|
ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting | NA | 0.28 | 0.1739 | 31100681
|
ABCG2 | 74 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Western Blotting and SP assay | NA | 0.28 | 0.1739 | 26911281
|
NANOG | 20857 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5461 | 34209829
|
POU5F1 | 9221 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.6448 | 34209829
|
SOX2 | 11195 | LTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by qRT-PCR | NA | 0.2 | 0.5695 | 34209829
|
A2M | 7 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
AARD | 33842 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
ABCA9-AS1 | 39983 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
AKAP8 | 378 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ALKBH6 | 28243 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ANKRD20A12P | 43603 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ANKRD52 | 26614 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ANKRD53 | 25691 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
AP4B1 | 572 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
APTR | 44173 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ARHGAP31 | 29216 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
ARID1A | 11110 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
ARID5A | 17361 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34059086
|
ASAP3 | 14987 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ATAD3C | 32151 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ATF7IP | 20092 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ATP2A1 | 811 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
AURKA | 11393 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
BAHD1 | 29153 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
BAX | 959 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 34059086
|
BAZ2A | 962 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
BCOR | 20893 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
BPESC1 | 13228 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
BRCA1 | 1100 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
BRWD1 | 12760 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
BTN3A2 | 1139 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
C16ORF82 | 30755 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
C9ORF85 | 28784 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
CABIN1 | 24187 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
CAT | 1516 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34059086
|
CBL | 1541 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
CCBL1 | 1564 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
CCDC130 | 28118 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
CCDC65 | 29937 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
CCL23 | 10622 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
CDC20 | 1723 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
CELA3B | 15945 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
CEP83 | 17966 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
CHAC2 | 32363 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
CHAD | 1909 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
CKMT1A | 31736 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
CLPTM1L | 24308 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
CLRN1 | 12605 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
CNST | 26486 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
COLEC10 | 2220 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
COPS7A | 16758 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
CORO1B | 2253 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
CPEB1 | 21744 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
CRYBG2 | 17295 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
CRYGS | 2417 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
CYB561 | 2571 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
CYP2R1 | 20580 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
CYP4F2 | 2645 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
DCAF12 | 19911 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
DDB1 | 2717 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
DEFB136 | 34433 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
DEXI | 13267 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
DGCR5 | 16757 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
DLG5 | 2904 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
DST | 1090 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
DUX4 | 50800 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
DYNC2I1 | 21862 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
EFHC1 | 16406 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
EIF2D | 6583 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
EIF2D | 6583 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
EMC6 | 28430 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
EMC8 | 7864 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ENOPH1 | 24599 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
EPHB1 | 3392 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ERO1A | 13280 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34059086
|
ESYT3 | 24295 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
ETFDH | 3483 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
EXOSC6 | 19055 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
FAM238B | 44917 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
FAM98B | 26773 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
FBXO42 | 29249 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
FGD5P1 | 44498 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
FHAD1 | 29408 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
FHL2 | 3703 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 34059086
|
FLJ46363 | NA | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
FLOT2 | 3758 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
FPGT-TNNI3K | 42952 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
GCOM1 | 26424 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
GINS2 | 24575 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
GLRA2 | 4327 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
GLTPD2 | 33756 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
GPALPP1 | 20298 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
GPR155 | 22951 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
GPR157 | 23687 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
GPR179 | 31371 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
GRM7 | 4599 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
GSPT2 | 4622 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
GSTCD | 25806 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
GTF2H2C_2 | 35418 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
GTPBP1 | 4669 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
HAO1 | 4809 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
HORMAD2-AS1 | 50729 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
HTR2A | 5293 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
IFI30 | 5398 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34059086
|
IGFBP2 | 5471 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34059086
|
ILDR2 | 18131 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
IQCJ-SCHIP1 | 38842 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
JPT1 | 14569 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
KBTBD11-OT1 | 49147 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
KBTBD6 | 25340 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
KCP | 17585 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
KIRREL2 | 18816 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
KLB | 15527 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
KLHL6-AS1 | 40850 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
KRTAP10-10 | 22972 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
LINC00240 | 18772 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
LINC00865 | 45170 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
LINC00877 | 27706 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
LINC00885 | 48571 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
LINC00989 | 48918 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
LINC01016 | 48991 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
LINC01121 | 49266 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
LINC01152 | 16752 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
LINC01304 | 50472 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
LINC01493 | 51150 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
LINC01514 | 51207 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
LINS1 | 30922 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
LOC124902802 | NA | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
LRATD2 | 24166 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
LRIG1 | 17360 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 34059086
|
LYRM4 | 21365 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
MAPK12 | 6874 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
MAPK8IP2 | 6883 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
MAPKAPK3 | 6888 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
ME2 | 6984 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
MEF2C | 6996 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
MFSD9 | 28158 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
MGST2 | 7063 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0042 | 34059086
|
MIR940 | 33683 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
MLANA | 7124 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
MMP25-AS1 | 51372 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
MR1 | 4975 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
MROH1 | 26958 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
MTFP1 | 26945 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
MTRNR2L2 | 37156 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
NCRNA00250 | NA | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
NECAP1 | 24539 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
NGEF | 7807 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
NGRN | 18077 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
NIFK-AS1 | 27385 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
NKD1 | 17045 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
NOL4L | 16106 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
NPPA | 7939 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
NRG2 | 7998 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
NSUN6 | 23529 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
NUMA1 | 8059 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
OR10Z1 | 14996 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
OR5AK2 | 15251 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
PCLAF | 28961 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
PEPD | 8840 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
PGD | 8891 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0053 | 34059086
|
PILRA | 20396 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
PLOD1 | 9081 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
PLPPR4 | 23496 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
PNCK | 13415 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
PNPLA2 | 30802 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
POLA2 | 30073 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
POLD2 | 9176 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
PPIL4 | 15702 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
PPP1R21 | 30595 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
PPP1R26 | 29089 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
PQLC2 | 26001 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
PSME4 | 20635 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
PSMF1 | 9571 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
PVRIG | 32190 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
RAB39A | 16521 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
RAB9B | 14090 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
RAC1 | 9801 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
RAD21L1 | 16271 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
RASD1 | 15828 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
RBBP4 | 9887 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
RBPMS | 19097 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
REV1 | 14060 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
RFC5 | 9973 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
RLIM | 13429 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
RNF186 | 25978 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
RNU6ATAC | 34017 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
RPL21 | 10313 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
RPL3 | 10332 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
RPL37A | 10348 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
RPL7 | 10363 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
RPRD1B | 16209 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
RSBN1L | 24765 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
RTN4IP1 | 18647 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
RXRG | 10479 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
SCGB3A1 | 18384 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
SELENOV | 30399 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
SH2D5 | 28819 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
SHISA7 | 35409 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
SIRPG-AS1 | 51229 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
SLC25A6 | 10992 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
SLC2A9 | 13446 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
SLC33A1 | 95 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
SLC47A1 | 25588 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
SLC4A2 | 11028 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
SLC5A11 | 23091 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
SMAD5 | 6771 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
SMAD9 | 6774 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
SNAP25-AS1 | 44312 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
SNORA78 | 32664 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
SNORD5 | 32702 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
SPIDR | 28971 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
SPTLC1 | 11277 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
SREK1IP1 | 26716 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
SRP9 | 11304 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
STXBP5-AS1 | 44183 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
STYXL1 | 18165 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
SUGP2 | 18641 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
SX2 | NA | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
SYNJ2BP-COX16 | 48350 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
TDRD7 | 30831 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
TEKT4P2 | 40046 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
TEX13B | 11736 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
TGFB1 | 11766 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0138 | 34059086
|
TMEM176B | 29596 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
TNFSF9 | 11939 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
TNXB | 11976 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
TRIM66 | 29005 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
TSHR | 12373 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
TSPYL1 | 12382 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
TTC9B | 26395 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
TUBGCP6 | 18127 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
UNC13C | 23149 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
UNC5B | 12568 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
USP11 | 12609 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
USP12-AS1 | 39961 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
VAC14-AS1 | 48605 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
VAMP4 | 12645 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
VCPIP1 | 30897 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
VTI1A | 17792 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
VWA8 | 29071 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
WASF1 | 12732 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0032 | 34059086
|
WNK2 | 14542 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
XAB2 | 14089 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
XKR6 | 27806 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
XPO7 | 14108 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
YWHAH | 12853 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
ZBTB21 | 13083 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ZC3HAV1 | 23721 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ZFP36L2 | 1108 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ZFTA | 28449 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ZFYVE28 | 29334 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ZNF468 | 33105 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0021 | 34059086
|
ZNF496 | 23713 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ZNF555 | 28382 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ZNF586 | 25949 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|
ZZEF1 | 29027 | HTM | Non Small Cell Lung Cancer | Squamous Cell Carcinoma | H292 | NA | SFA followed by Transcriptomics | Down | 0.04 | 0.0011 | 34059086
|